Clinical trial
Targeting Pathogenic Myelopoiesis in Pancreatic Cancer
NCT07765316 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeting Pathogenic Myelopoiesis in Pancreatic Cancer
- Lead sponsor
- IRCCS San Raffaele
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- December 31, 2029
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.